Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes Mellitus Type II: early-phase trial registry
1 of 8 indexed Diabetes Mellitus Type II trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 1 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Diabetes Mellitus Type II: 8 US clinical trials tracked, 1 recruiting.
Diabetes Mellitus Type II is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Golo, running 1 of these trials.
Enrollment posture brief
Registry condition diabetes-mellitus-type-ii
OPEN 1 | RECR 13% | LATE 1 | EARLY 3 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)
Diabetes Mellitus Type II lists 1 open slots (13% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes Mellitus Type II on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes Mellitus Type II is recruiting below its size-band peers.
1 of 8 indexed trials (12.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes Mellitus Type II trials is spread across many organizations.
Golo accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes Mellitus Type II enrolment sits around 132 participants.
Median target enrolment is 132 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Diabetes Mellitus Type II research is mostly interventional.
7 interventional and 1 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
University of Colorado, Denver
NCT07011147
Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana
Fairbanks Institute
NCT01386801
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
Pfizer
NCT02175121
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
Halozyme Therapeutics
NCT01194258
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
Hua Medicine Limited
NCT06498284
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
Mountain Diabetes and Endocrine Center
NCT01654120
TARDIS - Photo Elicitation and Intervention
VA Office of Research and Development
NCT06972251
GOLO Open-Label Pilot 1
Golo
NCT03478202
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes Mellitus Type II records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes Mellitus Type II trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes Mellitus Type II page
8 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Diabetes Mellitus Type II trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Golo sponsors the most Diabetes Mellitus Type II trials on record, review their full trial history before evaluating a specific study. See Golo's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes Mellitus Type II condition card totals 8 registered trials; most-linked intervention TARDIS Intervention; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.